Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New data on lithium and haloperidol incompatibility.

G Spring, M Frankel

    The American Journal of Psychiatry
    |June 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Response to correspondence by Johan Øvrevik.

    Indoor air·2014
    Same author

    Right unilateral thoracic spondylosis.

    The Journal of the Faculty of Radiologists. Faculty of Radiologists (Great Britain)·2014
    Same author

    An observer finds that Russian hospitals aren't so different.

    Modern hospital·2014
    Same author

    Effect of relative humidity on the aerosolization and total inflammatory potential of fungal particles from dust-inoculated gypsum boards.

    Indoor air·2013
    Same author

    Comparison of sampling methods for the assessment of indoor microbial exposure.

    Indoor air·2012
    Same author

    Synthesis of lysine anhydride.

    Journal of the American Chemical Society·2010

    Combined lithium and haloperidol toxicity can cause severe symptoms like hyperpyrexia and rigidity, potentially leading to irreversible tardive dyskinesia. This highlights the risks of combining these medications, necessitating careful monitoring.

    Area of Science:

    • Neuropharmacology
    • Clinical Toxicology

    Background:

    • Lithium and haloperidol are commonly prescribed medications.
    • Concurrent use can lead to severe adverse events.
    • Understanding toxicity profiles is crucial for patient safety.

    Observation:

    • A case of combined lithium and haloperidol toxicity presented with hyperpyrexia, severe rigidity, and mutism.
    • The patient developed irreversible tardive dyskinesia.
    • This presentation resembles neuroleptic malignant syndrome.

    Findings:

    • Two distinct types of combined lithium-neuroleptic toxicity are postulated.
    • Type 1: Neuroleptic malignant extrapyramidal syndrome.
    • Type 2: Lithium toxicity with phenothiazines (e.g., thioridazine).

    Related Experiment Videos

    Implications:

    • Highlights the potential for severe drug interactions.
    • Suggests specific mechanisms for combined toxicity.
    • Emphasizes the need for preventive strategies and cautious co-prescription.